EUVIMEDEUVIMED entdecken
Übersichtsarbeit

T cells in cardiovascular disease: solved and unsolved mysteries

Yangfeng Hou, Wentao Gao, Bin Zhou, Kathy O Lui

Science China Life Sciences · 2026

DOI: 10.1007/s11427-024-2976-8 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Science China Life Sciences, 2026. Verfasst von Yangfeng Hou und 3 weiteren Autor:innen. Beteiligte Einrichtung: CAS CEMCS-CUHK Joint Laboratory for Cardiovascular Sciences, Department of Chemical Pathology, Li Ka Shing Institute of Health Science, Prince of Wal…. Hauptthemen laut MEDLINE: Cardiovascular Diseases, T-Lymphocytes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 183 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular disease has been the leading cause of death worldwide for the past 30 years. Recent studies using single cell multiomics analysis have revealed that CD3+ T cells are among the most predominant cell types in diseased human cardiac and vascular tissues. Accumulating evidence has demonstrated the critical role of T cells in various cardiovascular diseases, including atherosclerosis, hypertension, myocardial infarction, neonatal heart injuries, autoimmune myocarditis, aortic aneurysm, and diabetic endothelial dysfunction. Recent research has also highlighted the therapeutic potential of CD4+ regulatory T (Treg) cells in promoting cardiovascular repair. In this review, we provide a systematic overview of how T cells regulate cardiovascular development, disease progression, and repair. We further discuss current and emerging therapeutic strategies, particularly those targeting Treg cells, aimed at reducing the incidence of cardiovascular events. Finally, we outline key areas for future investigation, including the identification of cardiovascular antigens that trigger T cell activation, the role of T cell aging in cardiovascular disease, and the molecular mechanisms underlying T cell function in the cardiovascular system. A deeper understanding of T cell biology could pave the way for novel, antigen-specific therapeutic interventions to prevent and treat cardiovascular diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesT-LymphocytesHumansAnimalsT-Lymphocytes, RegulatoryLymphocyte Activation

Stichwörter der Autor:innen

CD4+ T cellsCD8+ T cellsTreg cellscardiovascular disease

Autor:innen und Institutionen

  • CAS CEMCS-CUHK Joint Laboratory for Cardiovascular Sciences, Department of Chemical Pathology, Li Ka Shing Institute of Health Science, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, 999077, C…
  • Shenzhen Research Institute, The Chinese University of Hong Kong, Shenzhen, 518000, China.
  • CAS CEMCS-CUHK Joint Laboratory for Cardiovascular Sciences, New Cornerstone Investigator Institute, State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Mo…

Zitieren

APA

Hou, Y., Gao, W., Zhou, B., & Lui, K. O. (2026). T cells in cardiovascular disease: solved and unsolved mysteries. Science China Life Sciences. https://doi.org/10.1007/s11427-024-2976-8

Vancouver

Hou Y, Gao W, Zhou B, Lui KO. T cells in cardiovascular disease: solved and unsolved mysteries. Science China Life Sciences. 2026. doi:10.1007/s11427-024-2976-8

BibTeX
@article{Hou2026,
  author = {Hou, Yangfeng and Gao, Wentao and Zhou, Bin and Lui, Kathy O},
  title = {T cells in cardiovascular disease: solved and unsolved mysteries},
  journal = {Science China Life Sciences},
  year = {2026},
  doi = {10.1007/s11427-024-2976-8}
}
Kostenlos starten →